Latest News about JNJ
Recent news which mentions JNJ
Why Is Catalent (NYSE:CTLT) Stock Up 20% Today?
February 06, 2023
From InvestorPlace
Johnson & Johnson's Latest Talcum Powder Development Could Be Costly
February 06, 2023
From Motley Fool
Danaher Shows Interest In Acquiring Catalent Valued At Significant Premium: Report
February 06, 2023
From Benzinga
2 Reasons to Buy Johnson & Johnson, and 2 Reasons to Sell
February 05, 2023
Tickers
JNJ
From Motley Fool
2 Stocks Down More Than 6% to Buy Right Now
February 04, 2023
From Motley Fool
3 Unstoppable Dividend Stocks to Buy in February
February 04, 2023
From Motley Fool
3 Dow Stocks That Make for Screaming Buys in February
February 03, 2023
From Motley Fool
Johnson & Johnson's Upcoming Lung Cancer Data Could Offer Another Blockbuster Opportunity, Says Analyst
February 02, 2023
From Benzinga
3 Defensive Stocks to Buy If You Think the Market Is Headed Lower
February 02, 2023
From InvestorPlace
From Motley Fool
3 Dividend Stocks to Buy in 2023 for a Lifetime of Passive Income
February 02, 2023
From Motley Fool
This Low-Risk ETF Can Turn $39,000 Into $1 Million in 25 Years
February 02, 2023
From Motley Fool
3 Stocks You Can Confidently Buy in a Market Downturn
February 01, 2023
From Motley Fool
3 Warren Buffett Stocks to Buy Hand Over Fist in February
February 01, 2023
From Motley Fool
Earnings Roundup: Tesla, Intel, Chevron, and More
January 31, 2023
From Motley Fool
The 7 Best Climate Change Stocks to Buy for 2023
January 31, 2023
From InvestorPlace
These 20 stocks led the January rally
January 31, 2023
From MarketWatch
From Benzinga
US Court Rejects Johnson & Johnson's Controversial Ploy To Evade Talc Cancer Lawsuits
January 31, 2023
Tickers
JNJ
From Benzinga
Is Visa Stock a Buy?
January 31, 2023
From Motley Fool
Why Johnson & Johnson Stock Slipped by Nearly 4% on Monday
January 30, 2023
Tickers
JNJ
From Motley Fool
These 2 Stocks Led the Dow Lower Monday
January 30, 2023
From Motley Fool
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
January 30, 2023
From Benzinga
These 2 dividend-stock ETFs are more like growth funds in disguise. Can either still work in your income portfolio?
January 30, 2023
From MarketWatch
3 Dividend Kings to Buy Hand Over Fist in 2023
January 30, 2023
From Motley Fool
2 Blue Chips Under Pressure
January 29, 2023
From Motley Fool
3 Beaten-Down Blue Chip Stocks to Buy Right Now
January 29, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.